Four US Companies Align to Kickstart Canada’s Privatized Medical Marijuana Market
February 6th, 2014
News, Top Story
With Canada’s medical marijuana business shifting to a free market, U.S. companies are quickly and strategically crossing the border to take advantage of all this $1 billion industry has to offer. Under the country’s “Marihuana for Medical Purposes Regulations” (MMPR), the planned transfer of production of medical marijuana to centralized commercial producers is expected to take place in April of this year. Growers are not the only businesses expected to gain in this new market; security firms, consultancies, and other cannabis-related companies can also expect to find their products and services in greater demand in this new legalized program. Among these, four companies in particular stand out for their ability to anticipate regulatory changes, position themselves to take advantage of opportunities in this new environment and establish alliances that enable them to maximize their collective opportunity for success: Creative Edge nutrition (OTC Pink: FITX), Endexx Corporation (OTC Pink: EDXC), GrowLife, Inc. (OTCBB: PHOT) and RXNB Inc.
The Canadian Government has received several hundred applications from eager businesses ready to serve as legal marijuana producers once the new free market medical marijuana laws go into effect later this year. Only 3 have been approved by he government so far, with another 4 or 5 anticipated to follow suit.
Those with knowledge of the application process stress that what makes a company an acceptable candidate to Canadian authorities is a vigilant focus on quality control and compliance with government regulations at the forefront of operations. Equally important is a diverse and scalable business model, particularly in light of Health Canada’s prediction of 500,000 medicinal marijuana users in the country by 2023.
Creative Edge has been actively positioning itself to join the ranks of the approved. The company began as a sports, vitamin and diet supplement provider, but when they recognized the potential of the medical marijuana market, they introduced hemp and eventually THC to its product lineup. This experience served them well when Canada announced that it was shifting medical marijuana production from the government to the private sector – the company was able to mobilize quickly and begin the process to obtain one of the few licenses the Canadian government will grant to grow, import, and export marijuana.
In particular, Creative Edge has been issued a ‘ready to build’ letter for a facility by Health Canada, and the company is currently constructing a 58,000 square-foot, state-of-the-art grow and distribution facility in Lakeshore, Ontario. With this facility in place,l they are poised to become the first U.S. company to grow and sell medicinal marijuana backed by a sovereign nation.
This facility serves as an important element of the company’s license application – but analysts note that there are other elements that make it even more compelling. While the Canadian government requires only a 15-page application, Creative Edge has submitted a 900-page strategy. It highlights not only the company’s own strengths, but also the combined expertise they bring to bear through the support of what they consider a ‘dream team’ of supporting enterprises: Endexx, GrowLife and RXNB.
Endexx Corporation is the company’s compliance and technology partner, responsible for ensuring that the company meets all applicable regulatory requirements through its M3Hub Seed-to-Sale Management technology platform. The M3Hub, which exceeds Health Canada’s compliance thresholds, will bring a high level of sustainability to the Creative Edge operation through its sophisticated standardization and reliable compliance methodology. EDXC’s M3Hub creates a web of traceable connections between all critical touch points in the supply chain process, from seed and nutrients to soil management and harvesting to packaging and shipping. The technology platform also integrates security monitoring, personnel identification and barcoding, while increasing overall process efficiencies. Claiming the potential for 40% increase in productivity, EDXC will be instrumental in reducing labor expenses, accelerating crop cycles, and outlining best practices for regulatory compliance under Canada’s MMPR.
Also joining forces is industry leader GrowLife, Inc. Grow Life has entered into a series of agreements with Creative Edge to serve as the exclusive supplier of growing equipment for the production facility, which is expected to be the largest and most advanced legal cannabis production facility in the world. Together, the companies anticipate 1.3 million pounds of dried medical marijuana to be produced annually. Importantly, the surrounding agricultural region eagerly welcomes the possible growth in jobs and economic activity. With this projected volume and pace, the enterprise is well positioned to serve markets well beyond Canada – there are currently 29 countries with legalized medical marijuana programs, each of which represents a considerable revenue opportunity.
Rounding out the strategic alliance is RNXB, which has numerous patents pending in the field of THC research and development and processes. FITX and RXNB will work closely to incorporate current good manufacturing practices (cGMP) that allows for a perpetual grow cycle in a sterile environment to inhibit adulteration or infestation of crops, a big selling point for Health Canada.
Together, these companies offer reliable, proven platforms and the ability to manage stable growth – something they expect to be particularly attractive to regulators. Moreover, their combination of secure financing, strong backgrounds in nutrition and security, and the transparency that comes from being publically traded have all contributed to their appeal not only to the Canadian government, but to investors as well.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.